point of care company 1 timeline, page-24

Oslo, great find, I wasn't planning on posting for a while, but credit where credit is due. Interesting that Troponin is only relatively recently become the marker of choice for MI. I wonder how long the previous ones were used before Troponin took over. Better yet, I wonder of M&G can help in whatever comes next ;) maybe something else that's currently not detectable without M&G

Muppet, love your work. Makes sense to me and gets rid of some concerns I had. Thank you. You say "a quick negative..." is that what we refer to as specificity? If the new device in say 99.99% accurate when detecting a negative, is that enough given the seriousness of the situation? Does it need to be 100%?

Propagandista - well done on replying. And contributing to a robust discussion. Better than any other contrarian on this thread in the past... you know who you are! I hope you become a shareholder soon and profit like the rest of us

All- What if the Philips device plans on detecting more than just troponin? I believe they call this multiplexing? Would it then be more beneficial?

I will be increasing my stake should there be weakness due to overall market sentiment today (in my wife's name)